End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,405 KRW | -0.82% | +1.26% | -15.32% |
Business Summary
Number of employees: 75
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
68.3
%
| 32,840 | 67.4 % | 27,454 | 68.3 % | -16.40% |
Fabric
31.7
%
| 15,878 | 32.6 % | 12,749 | 31.7 % | -19.71% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Overseas
89.7
%
| 44,180 | 90.7 % | 36,077 | 89.7 % | -18.34% |
South Korea
10.3
%
| 4,538 | 9.3 % | 4,126 | 10.3 % | -9.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Young-Geun Park
CEO | Chief Executive Officer | 60 | - |
Won-Il Kim
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Byung-Moon Cho
BRD | Director/Board Member | 64 | - |
Jae-Kyung Chae
PRN | Corporate Officer/Principal | 55 | - |
Seong-Ho Choi
AUD | Comptroller/Controller/Auditor | 61 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Byung-Moon Cho
BRD | Director/Board Member | 64 | - |
Young-Geun Park
CEO | Chief Executive Officer | 60 | - |
Sang-Don Kim
BRD | Director/Board Member | 58 | 30/03/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 78,473,817 | 71,452,301 ( 91.05 %) | 209,464 ( 0.2669 %) | 91.05 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
209,464 | 0.27% | 394,423 $ |
Company contact information
GeneOne Life Science, Inc.
20th Floor, Park1 NH Financial Tower 108 Yeoui-daero
07335, Seoul
+
http://www.genels.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-15.32% | 142M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- A011000 Stock
- Company GeneOne Life Science, Inc.